Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
166 studies found for:    Open Studies | "Niacin"
Show Display Options
Rank Status Study
21 Unknown  Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)
Conditions: Dyslipidemia;   Atherosclerosis
Interventions: Drug: simvastatin;   Drug: Nicotinic Acid
22 Not yet recruiting Use of 31P MRS to Assess Brain NAD+ in Healthy Collegiate Football Players
Condition: Concussion, Mild
Interventions: Dietary Supplement: Nicotinamide Riboside;   Other: Matching placebo
23 Unknown  Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow
Condition: Female Sexual Dysfunction
Interventions: Drug: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%;   Drug: Topical study cream;   Drug: GRAS cream
24 Recruiting Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Condition: Dyslipidemia
Interventions: Drug: ALIROCUMAB SAR236553 (REGN727);   Drug: placebo;   Drug: statins;   Drug: ezetimibe;   Drug: fenofibrate;   Drug: nicotinic acid;   Drug: omega-3 fatty acids
25 Recruiting An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Condition: Hypercholesterolaemia
Interventions: Drug: alirocumab SAR236553 (REGN727);   Drug: statins;   Drug: ezetimibe;   Drug: cholestyramine;   Drug: fenofibrate;   Drug: omega-3 fatty acids;   Drug: nicotinic acid
26 Recruiting A Study Investigating the Effects of Niagen™ in Healthy Adults.
Condition: Bioavailability
Interventions: Dietary Supplement: Niagen™ 100;   Dietary Supplement: Niagen™ 300;   Dietary Supplement: Niagen™ 1000;   Other: Placebo
27 Recruiting Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
Condition: Diarrhea
Interventions: Dietary Supplement: MNP;   Dietary Supplement: preventive zinc supplement;   Dietary Supplement: therapeutic zinc supplement;   Dietary Supplement: preventive placebo supplement;   Dietary Supplement: therapeutic placebo supplement;   Dietary Supplement: placebo powder
28 Unknown  A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)
Condition: Schizophrenia
Intervention:
29 Recruiting Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
Condition: Congenital Heart Disease
Interventions: Dietary Supplement: Vitamin B Complex and Folic Acid;   Dietary Supplement: Iron and Folic Acid;   Dietary Supplement: Folic Acid
30 Unknown  Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex
Conditions: Lack of Appetite;   Anorexia
Interventions: Drug: Apevinat BC;   Drug: Vitamin Complex
31 Recruiting Comparison of Two Nutrition Interventions in Young Children in El Salvador
Condition: Micronutrient Deficiency
Interventions: Dietary Supplement: 21 micronutrient-fortified supplement;   Dietary Supplement: Cereal Fortificado (Fortified Cereal);   Dietary Supplement: Ferrous sulphate;   Dietary Supplement: Vitamin A
32 Not yet recruiting Impact of isoQUercetin and Aspirin on Platelet Function
Condition: Cardiovascular Disease
Interventions: Drug: Vehicle control;   Drug: Isoquercetin;   Drug: Aspirin;   Drug: Isoquercetin plus Aspirin
33 Unknown  Prostate Cancer Prevention Trial With Quercetin and Genistein
Condition: Primary Prevention of Prostate Cancer
Interventions: Dietary Supplement: Quercetin supplement;   Dietary Supplement: Genistein supplement;   Dietary Supplement: Placebo
34 Unknown  Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases
Conditions: Preeclampsia;   Pregnancy;   Micronutrients;   Exercise
Interventions: Behavioral: Regular aerobic physical exercise;   Dietary Supplement: Micronutrients;   Other: Activities of daily living + placebo
35 Not yet recruiting Early Child Development and Nutrition in Guatemala
Condition: Undernutrition
Interventions: Dietary Supplement: Micronutrients;   Behavioral: Responsive feeding;   Dietary Supplement: Placebo
36 Recruiting Randomized Phase II Trial of Chemoembolization and Sorafenib
Condition: Hepatocellular Carcinoma
Interventions: Drug: conventional TACE in combination with sorafenib, administered on a continuous schedule;   Drug: conventional TACE in combination with sorafenib, administered on a sequential schedule
37 Recruiting Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection
Conditions: Hepatocellular Carcinoma;   Recurrence
Intervention: Drug: Sorafenib
38 Not yet recruiting Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC)
Intervention: Biological: Sorafenib plasma concentration 4 weeks after treatment initiation
39 Recruiting Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Drug: Dasatinib;   Drug: Idarubicin;   Other: Laboratory Biomarker Analysis;   Drug: Nilotinib;   Drug: Ponatinib Hydrochloride;   Drug: Sorafenib Tosylate;   Drug: Sunitinib Malate
40 Recruiting Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib;   Procedure: Hepatic arterial infusion chemotherapy;   Drug: Oxaliplatin , fluorouracil, and leucovorin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years